- JNCE Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Jounce Therapeutics (JNCE) 8-K1 Sep 20Gilead Sciences and Jounce Therapeutics Announce Exclusive License Agreement for Novel Immunotherapy ProgramFinancial data
Company Profile